BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32813115)

  • 1. G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival.
    Schüler-Toprak S; Skrzypczak M; Ignatov T; Ignatov A; Ortmann O; Treeck O
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3175-3188. PubMed ID: 32813115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
    Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O
    Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro.
    Han N; Heublein S; Jeschke U; Kuhn C; Hester A; Czogalla B; Mahner S; Rottmann M; Mayr D; Schmoeckel E; Trillsch F
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel estrogen receptor GPER mediates proliferation induced by 17β-estradiol and selective GPER agonist G-1 in estrogen receptor α (ERα)-negative ovarian cancer cells.
    Liu H; Yan Y; Wen H; Jiang X; Cao X; Zhang G; Liu G
    Cell Biol Int; 2014 May; 38(5):631-8. PubMed ID: 24446390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
    Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
    Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.
    Heublein S; Mayr D; Vrekoussis T; Friese K; Hofmann SS; Jeschke U; Lenhard M
    PLoS One; 2013; 8(8):e71791. PubMed ID: 23951246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
    Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells.
    Schüler-Toprak S; Moehle C; Skrzypczak M; Ortmann O; Treeck O
    BMC Cancer; 2017 May; 17(1):319. PubMed ID: 28482871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer.
    Lee SJ; Kim TW; Park GL; Hwang YS; Cho HJ; Kim JT; Lee HG
    BMB Rep; 2019 Nov; 52(11):647-652. PubMed ID: 31234952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells.
    Weißenborn C; Ignatov T; Poehlmann A; Wege AK; Costa SD; Zenclussen AC; Ignatov A
    J Cancer Res Clin Oncol; 2014 Apr; 140(4):663-71. PubMed ID: 24515910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled estrogen receptor 1 agonist G-1 induces cell cycle arrest in the mitotic phase, leading to apoptosis in endometriosis.
    Mori T; Ito F; Matsushima H; Takaoka O; Tanaka Y; Koshiba A; Kusuki I; Kitawaki J
    Fertil Steril; 2015 May; 103(5):1228-35.e1. PubMed ID: 25724739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPER functions as a tumor suppressor in triple-negative breast cancer cells.
    Weißenborn C; Ignatov T; Ochel HJ; Costa SD; Zenclussen AC; Ignatova Z; Ignatov A
    J Cancer Res Clin Oncol; 2014 May; 140(5):713-23. PubMed ID: 24553912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo.
    Chimento A; Sirianni R; Casaburi I; Zolea F; Rizza P; Avena P; Malivindi R; De Luca A; Campana C; Martire E; Domanico F; Fallo F; Carpinelli G; Cerquetti L; Amendola D; Stigliano A; Pezzi V
    Oncotarget; 2015 Aug; 6(22):19190-203. PubMed ID: 26131713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-protein-coupled estrogen receptor suppresses the migration of osteosarcoma cells via post-translational regulation of Snail.
    Wang Z; Chen X; Zhao Y; Jin Y; Zheng J
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):87-96. PubMed ID: 30341688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-Protein-Coupled Estrogen Receptor (GPER)-Specific Agonist G1 Induces ER Stress Leading to Cell Death in MCF-7 Cells.
    Vo DH; Hartig R; Weinert S; Haybaeck J; Nass N
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31540491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3.
    Yan Y; Jiang X; Zhao Y; Wen H; Liu G
    Cell Biochem Funct; 2015 Dec; 33(8):552-9. PubMed ID: 26526233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells.
    Yan Y; Liu H; Wen H; Jiang X; Cao X; Zhang G; Liu G
    Mol Cell Biochem; 2013 Jun; 378(1-2):1-7. PubMed ID: 23580092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPER Agonist G-1 Disrupts Tubulin Dynamics and Potentiates Temozolomide to Impair Glioblastoma Cell Proliferation.
    Hirtz A; Lebourdais N; Rech F; Bailly Y; Vaginay A; Smaïl-Tabbone M; Dubois-Pot-Schneider H; Dumond H
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
    Zekas E; Prossnitz ER
    BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
    Li Y; Birnbaumer L; Teng CT
    Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.